Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial.
Saved in:
| Title: | Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial. |
|---|---|
| Authors: | Mc Causland FR; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: fmccausland@bwh.harvard.edu., Vaduganathan M; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Claggett B; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Gori M; Cardiology Division, Cardiovascular Department, Azienda Ospedaliera Papa Giovanni XXIII Hospital, Bergamo, Italy., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., McGrath MM; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA., Neuen BL; George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia; Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA., Pfeffer MA; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada., Senni M; Cardiology Division, Cardiovascular Department, Azienda Ospedaliera Papa Giovanni XXIII Hospital, Bergamo, Italy., Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden., Zannad F; Inserm CIC1433, CHRU de Nancy, Université de Lorraine, Nancy, France., Zile M; Medical University of South Carolina, Charleston, South Carolina, USA; Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina, USA., Lefkowitz MP; Novartis Pharmaceuticals, East Hanover, New Jersey, USA., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Solomon SD; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. |
| Source: | JACC. Heart failure [JACC Heart Fail] 2025 Jan; Vol. 13 (1), pp. 105-114. Date of Electronic Publication: 2024 Nov 20. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39570234 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mc+Causland+FR%22">Mc Causland FR</searchLink>; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: fmccausland@bwh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Vaduganathan+M%22">Vaduganathan M</searchLink>; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Claggett+B%22">Claggett B</searchLink>; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gori+M%22">Gori M</searchLink>; Cardiology Division, Cardiovascular Department, Azienda Ospedaliera Papa Giovanni XXIII Hospital, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Jhund+PS%22">Jhund PS</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McGrath+MM%22">McGrath MM</searchLink>; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Neuen+BL%22">Neuen BL</searchLink>; George Institute for Global Health, UNSW Sydney, Sydney, New South Wales, Australia; Department of Renal Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Packer+M%22">Packer M</searchLink>; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Pfeffer+MA%22">Pfeffer MA</searchLink>; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rouleau+JL%22">Rouleau JL</searchLink>; Institut de Cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Senni+M%22">Senni M</searchLink>; Cardiology Division, Cardiovascular Department, Azienda Ospedaliera Papa Giovanni XXIII Hospital, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Swedberg+K%22">Swedberg K</searchLink>; Department of Molecular and Clinical Medicine, University of Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Zannad+F%22">Zannad F</searchLink>; Inserm CIC1433, CHRU de Nancy, Université de Lorraine, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Zile+M%22">Zile M</searchLink>; Medical University of South Carolina, Charleston, South Carolina, USA; Ralph H. Johnson Department of Veterans Affairs Medical Center, Charleston, South Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Lefkowitz+MP%22">Lefkowitz MP</searchLink>; Novartis Pharmaceuticals, East Hanover, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22McMurray+JJV%22">McMurray JJV</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Solomon+SD%22">Solomon SD</searchLink>; Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101598241%22">JACC. Heart failure</searchLink> [JACC Heart Fail] 2025 Jan; Vol. 13 (1), pp. 105-114. <i>Date of Electronic Publication: </i>2024 Nov 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101598241 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2213-1787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222131779%22">22131779 </searchLink><i>NLM ISO Abbreviation: </i>JACC Heart Fail <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39570234 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jchf.2024.08.022 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 105 Titles: – TitleFull: Angiotensin Receptor Neprilysin Inhibition and Cardiovascular Outcomes Across the Kidney Function Spectrum: The PARAGON-HF Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mc Causland FR – PersonEntity: Name: NameFull: Vaduganathan M – PersonEntity: Name: NameFull: Claggett B – PersonEntity: Name: NameFull: Gori M – PersonEntity: Name: NameFull: Jhund PS – PersonEntity: Name: NameFull: McGrath MM – PersonEntity: Name: NameFull: Neuen BL – PersonEntity: Name: NameFull: Packer M – PersonEntity: Name: NameFull: Pfeffer MA – PersonEntity: Name: NameFull: Rouleau JL – PersonEntity: Name: NameFull: Senni M – PersonEntity: Name: NameFull: Swedberg K – PersonEntity: Name: NameFull: Zannad F – PersonEntity: Name: NameFull: Zile M – PersonEntity: Name: NameFull: Lefkowitz MP – PersonEntity: Name: NameFull: McMurray JJV – PersonEntity: Name: NameFull: Solomon SD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Jan Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2213-1787 Numbering: – Type: volume Value: 13 – Type: issue Value: 1 Titles: – TitleFull: JACC. Heart failure Type: main |
| ResultId | 1 |